NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
Starting HIV treatment
  • When to start treatment
    • Choosing a combination
      • Summary: Choosing a combination
      • What to start with
      • Choosing a nucleoside or nucleotide reverse transcriptase inhibitor backbone
      • Choosing a protease inhibitor
      • Choosing a non-nucleoside reverse transcriptase inhibitor
      • Other options
      • Options for simplifying therapy
      • Questions to ask your doctor
    support our work today
    YOU ARE HERE
    • > Home
      • > Treatment & Care
        • > Treatment & Care
          • > Starting HIV treatment

    Choosing a combination

    printer-friendly versionsend to a friendglossarycomment

    Details of how to choose an appropriate treatment combination, including the choice of drugs from each class, newer classes of drugs, and options for simplifying therapy.

    • Summary: Choosing a combination
    • What to start with
    • Choosing a nucleoside or nucleotide reverse transcriptase inhibitor backbone
    • Choosing a protease inhibitor
    • Choosing a non-nucleoside reverse transcriptase inhibitor
    • Other options
    • Options for simplifying therapy
    • Questions to ask your doctor

    latest aidsmap news

    • Updated British HIV pregnancy guidelines published
    • Incidence increasing of HIV-associated multicentric Castleman's disease, a relatively rare lymphatic cancer
    • Rapid progression of liver fibrosis in HIV-positive gay men recently infected with hepatitis C
    • Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
    • Long-term HIV treatment cuts risk of hardening of coronary artery
    • Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks
    • Will male circumcision protect women, ask advocates?
    • Do not use HIV tests bought over the internet, warns UK medicines regulators
    • `Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes
    • Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
     
    • Contact NAM
    • Get Email Updates
    • Disclaimer
    • Copyright
    • Developed By NAM